Are symptomatic changes in irritable bowel syndrome correlated with the capsule endoscopy transit time? A pilot study using the 5-HT4 receptor agonist mosapride.
Symptomatic changes in the irritable bowel syndrome are correlated with the capsule endoscopy transit time : A pilot study using the 5-HT4 receptor agonist mosapride